140 related articles for article (PubMed ID: 10846571)
61. Diagnostic value of AgNOR staining in thyroid cytology.
Shechtman L; Koren R; Horowitz A; Shechtman I; Halpern M; Gal R
Anal Quant Cytol Histol; 1998 Jun; 20(3):187-91. PubMed ID: 9642445
[TBL] [Abstract][Full Text] [Related]
62. An improved system for quantifying AgNOR and PCNA in canine tumors.
Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
[TBL] [Abstract][Full Text] [Related]
63. Value of argyrophilic nucleolar organizing region protein determinations in nondiagnostic fine needle aspiration samples (due to insufficient cell groups) of thyroid nodules.
Eröz R; Unluhizarci K; Cucer N; Ozturk F
Anal Quant Cytopathol Histpathol; 2013 Aug; 35(4):226-31. PubMed ID: 24341126
[TBL] [Abstract][Full Text] [Related]
64. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma.
Mourad WA; Sneige N; Katz RL; Ordóñez NG
Diagn Cytopathol; 1994; 10(2):113-9. PubMed ID: 8187588
[TBL] [Abstract][Full Text] [Related]
65. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
Gulbahar MY; Yuksel H; Guvenc T; Okut H
Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
[TBL] [Abstract][Full Text] [Related]
66. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status.
Mourad WA; Erkman-Balis B; Livingston S; Shoukri M; Cox CE; Nicosia SV; Rowlands DT
Cancer; 1992 Apr; 69(7):1739-44. PubMed ID: 1312892
[TBL] [Abstract][Full Text] [Related]
67. Argyrophilic staining for nucleolar organizer region (AgNOR). A suitable methodology for differential diagnosis of breast lesions?
Sivrides E; Anastasiadis P; von Lüdinghausen M
Zentralbl Pathol; 1992 Apr; 138(2):103-7. PubMed ID: 1610761
[TBL] [Abstract][Full Text] [Related]
68. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
69. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
[TBL] [Abstract][Full Text] [Related]
70. [The relationship between the prognosis of retinoblastoma and proliferating cell nuclear antigen and argyrophilic protein at nucleolus organizer regions].
Li D; Song X; Gao Y
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):293-6. PubMed ID: 10451965
[TBL] [Abstract][Full Text] [Related]
71. Silver binding nucleolar organizer regions in adrenocortical neoplasia.
Oz B; Dervisoglu S; Dervisoglu M; Oz O
Cytopathology; 1992; 3(2):93-9. PubMed ID: 1617165
[TBL] [Abstract][Full Text] [Related]
72. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
[TBL] [Abstract][Full Text] [Related]
73. Argyrophilic nucleolar organizer region (AgNOR) technique: a helpful tool for differential diagnosis in urinary cytology.
Cia EM; Trevisan M; Metze K
Cytopathology; 1999 Feb; 10(1):30-9. PubMed ID: 10068885
[TBL] [Abstract][Full Text] [Related]
74. [Quantitative study on nucleolar organizer regions in salivary gland tumours].
Wang SZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Mar; 27(2):74-6, 127. PubMed ID: 1337733
[TBL] [Abstract][Full Text] [Related]
75. Multiple biomarkers of colorectal tumor in a differential diagnosis model: a quantitative study.
Jin W; Gao MQ; Lin ZW; Yang DX
World J Gastroenterol; 2004 Feb; 10(3):439-42. PubMed ID: 14760775
[TBL] [Abstract][Full Text] [Related]
76. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses.
Wolanski KD; Whitaker D; Shilkin KB; Henderson DW
Cancer; 1998 Feb; 82(3):583-90. PubMed ID: 9452278
[TBL] [Abstract][Full Text] [Related]
77. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
[TBL] [Abstract][Full Text] [Related]
78. Argyrophilic nucleolar organizer regions in benign and malignant mesothelial lesions.
Vacharadze K; Burkadze G; Turashvili G; Kiria N
Georgian Med News; 2005 Nov; (128):91-3. PubMed ID: 16369075
[TBL] [Abstract][Full Text] [Related]
79. Argyrophilic nucleolar organizer regions and proliferating cell nuclear antigen/cyclin in Kaposi's sarcoma. Comparison with morphology and with immunoperoxidase staining for factor VIII-related antigen.
Haupt HM; Stern JB; Multhaupt H; Newman HW
Arch Pathol Lab Med; 1995 Jun; 119(6):538-41. PubMed ID: 7605171
[TBL] [Abstract][Full Text] [Related]
80. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis.
Guler N; Uckan S; Celik I; Oznurlu Y; Uckan D
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):900-6. PubMed ID: 15907374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
